Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2CNS 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 26Lymphoma 24Lymphoma, Follicular 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, Mantle-Cell 21Lymphoma, Large B-Cell, Diffuse 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, Large-Cell, Immunoblastic 19Burkitt Lymphoma 18Hodgkin Disease 16Lymphoma, B-Cell, Marginal Zone 14Leukemia 13Multiple Myeloma 9Neoplasms, Plasma Cell 7Leukemia, Myeloid, Acute 6Waldenstrom Macroglobulinemia 5Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Congenital Abnormalities 4Myelodysplastic Syndromes 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Dendritic Cell Sarcoma, Interdigitating 3Blast Crisis 3Testicular Neoplasms 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2

Interventions

Cyclophosphamide 8Flow Cytometry 6Methylprednisolone 5Melphalan 5Therapeutics 4Psychiatric Rehabilitation 4Busulfan 4Antilymphocyte Serum 4Radiotherapy 3Polymerase Chain Reaction 3Immunologic Techniques 3Filgrastim 3Caspofungin 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3venetoclax 2thymoglobulin 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Voriconazole 2Thiotepa 2Thalidomide 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Nivolumab 2Itraconazole 2Ipilimumab 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Carmustine × Other hematologic neoplasm × Clear all
NCT00536601 2021-04-22

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Roswell Park Cancer Institute

Phase NA Completed
174 enrolled 17 charts
CNSDermatologicGenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Neuroblastoma, Recurrence, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡